Crohn’s disease may be a lifelong condition, but today, there are an abundance of effective treatments that can help bring ...

Filgotinib, a JAK1 preferential inhibitor, shows promise as an effective and well-tolerated maintenance therapy for Crohn's ...

Nutrients specific to the Mediterranean diet could help with symptom management in inflammatory bowel disease, evidence ...

Crohn’s disease may be a lifelong condition ... In recent years, researchers have started to evaluate the role of certain diets in managing the symptoms of Crohn’s. We’re only just beginning ...

If you recently learned that you have Crohn’s disease, you’re not alone. According to the National Institutes of Health, ...

This positive opinion brings Omvoh closer to becoming the first Crohn's disease treatment to include improvements in histologic measures of inflammation on its label, if approved by the European ...

Lilly has submitted marketing applications for Omvoh in Crohn's disease around the globe, including the U.S. and Japan. Decisions are expected from these regulatory authorities starting in the ...

Eli Lilly (NYSE:LLY) has received a positive recommendation for approval from European regulators for its drug Omvoh in the treatment of Crohn’s disease. The European Medicines Agency's ...

Treating Newly-Diagnosed Crohn's Patients With Advanced Therapy ... Against Colitis in Inflammatory Bowel Disease Nov. 9, 2023 — High fiber diets, like those that include broccoli sprouts ...

The SELECTION study1 showed that the JAK 1 inhibitor filgotinib is safe and efficacious in ulcerative colitis. Based on positive results of the phase 2 FITZROY study2 in Crohn's disease, it was ...